Background: Epigenetic age acceleration (EAA) is a valuable tool for predicting all-cause mortality and assessing disease risk. Differences in EAA reflects biologic aging (BA) and suggests underlying differences in morbidities. We examined whether EAA moderated the association of dementia to mortality risk.
Method: Analyses are based on data from the Age, Gene/Environment Susceptibility- Reykjavik Study (AGES-RS) study (n = 2602, 57.5% females, mean age = 75.8 years, 30% demented). Data were collected from 2002 to 2006, with mortality data available until 2015. EAA was computed with the DunedinPACE algorithm and grouped as follows: EAA scores > 1 SD of the mean were labeled as 'fast', EAA < 1 SD as 'slow', and EAA scores within ±1 SD as 'average'. Dementia was ascertained in a study exam or through follow-up of health records. Cox proportional hazard analysis was used to evaluate the hazard ratio (HR, 95%CI) of mortality and the interaction between EAA and dementia. Models were adjusted for sex, chronological age, education, smoking, diabetes and stroke.
Result: Fast agers had higher mortality HRs than average agers (Figure 1A). Fast agers with dementia had a significantly increased risk of death (interaction p-value = 4.08×10) compared to non-demented average agers (Figure 1C); this interaction was reduced after adjusting for total brain volume (Figure 1B). Conversely, slow aging was associated with reduced mortality risk (HR = 0.71, 95% CI: 0.52-0.98, p-value = 3.62×10); however slow agers with dementia had risk estimates similar to non-demented average agers (interaction p-value = 1.14×10) but lower than demented fast agers. Controlling for total brain volume reduced the differences between slow and average agers with and without dementia.
Conclusion: Individuals aging at a faster rate than their chronological age were at a higher risk for death. The rate of BA had an effect on the association between dementia and mortality. The association was partially explained by brain atrophy, suggesting other factors related to dementia contributing to mortality risk in people with dementia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.089435 | DOI Listing |
Background: Epigenetic age acceleration (EAA) is a valuable tool for predicting all-cause mortality and assessing disease risk. Differences in EAA reflects biologic aging (BA) and suggests underlying differences in morbidities. We examined whether EAA moderated the association of dementia to mortality risk.
View Article and Find Full Text PDFFront Aging Neurosci
September 2024
Department of Neurology, Ewha Womans University Mokdong Hospital, Ewha Womans University, College of Medicine, Seoul, Republic of Korea.
Objective: Cognitive decline is often considered an inevitable aspect of aging; however, recent research has identified a subset of older adults known as "superagers" who maintain cognitive abilities comparable to those of younger individuals. Investigating the neurobiological characteristics associated with superior cognitive function in superagers is essential for understanding "successful aging." Evidence suggests that the gut microbiome plays a key role in brain function, forming a bidirectional communication network known as the microbiome-gut-brain axis.
View Article and Find Full Text PDFArch Clin Neuropsychol
August 2024
Rotman Research Institute, Baycrest Academy for Research and Education, Toronto, Ontario, Canada.
Superagers are 80 to 89-year-olds with average or better cognition and memory equivalent to individuals 20 to 30 years younger. As sex and modifiable lifestyle/health factors influence cognitive aging and dementia risk, we examined their impact on superager status. Data from participants (n = 469; 67% female) aged 80-89 years old were analyzed from an online database that included demographic and dementia risk factors, and performance on tasks assessing working memory, cognitive inhibition, associative memory, and set shifting.
View Article and Find Full Text PDFGeroscience
August 2024
Department of Psychology, University of Arizona, Tucson, AZ, USA.
Companion dogs are a valuable model for aging research, including studies of cognitive decline and dementia. With advanced age, some dogs spontaneously develop cognitive impairments and neuropathology resembling features of Alzheimer's disease. These processes have been studied extensively in laboratory beagles, but the cognitive assays used in that context-which rely on time-consuming operant procedures-are not easily scalable to large samples of community-dwelling companion dogs.
View Article and Find Full Text PDFNeuroimage
August 2022
Center for Vital Longevity, School of Behavioral and Brain Sciences, The University of Texas at Dallas, 1600 Viceroy Dr., Unit 800, Dallas, TX, 75235, USA.
Much neuroimaging research has explored the neural mechanisms underlying successful cognitive aging. Two different patterns of functional activation, maintenance of youth-like activity and compensatory novel recruitment, have been proposed to represent different brain functional features underlying individual differences in cognitive aging. In this study, we investigated the functional features in individuals across the adult lifespan who appeared to resist age-related cognitive decline, in comparison to those with typical age-related declines, over the course of four years.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!